StockWatch
·
Biotechnology: Pharmaceutical Preparations
Insider TradingMay 29, 2026, 04:49 PM

Genmab Director Michael Kavanagh Sells 526 Shares for DKK 1,734.75 Each

AI Summary

Genmab A/S announced that Michael Kavanagh, a Member of the Board of Directors, sold 526 shares of the company. The transactions took place on May 29, 2026, on NASDAQ Copenhagen, with each share sold at a price of DKK 1,734.75. This disclosure is made in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse.

Key Highlights

  • Michael Kavanagh, Member of the Board of Directors, sold shares.
  • Transaction involved the sale of Genmab A/S shares.
  • A total of 526 shares were sold.
  • Each share was sold at a price of DKK 1,734.75.
  • The transaction occurred on May 29, 2026.
  • The shares were traded on NASDAQ Copenhagen (XCSE).